Physician profile
Michael W Gray
NPI 1275734964
$2,034.54
in general payments reported to CMS, 2019-2025
16 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,041 · 2020: $181 · 2021: $246 · 2022: $101 · 2023: $66.94 · 2024: $265 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $464.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $1,349.25 | 2019-2021 | |
| Lumenis Be INC | $265.47 | 2024 | M22 |
| Allergan, INC. | $57.48 | 2019 | |
| Integra Lifesciences Corporation | $45.43 | 2025 | Integra, Surgimend, Omnigraft |
| Abbvie INC. | $44.95 | 2025 | |
| Medtronic, INC. | $44.17 | 2023 | V-Loc 180 |
| Solta Medical, A Division of Bausch Health US, LLC | $37.39 | 2019-2022 | |
| Atricure, INC. | $30.91 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $25.84 | 2022 | |
| Acelrx Pharmaceuticals, INC. | $22.79 | 2022 | |
| Galderma Laboratories, L.P. | $22.77 | 2023 | |
| Mckesson Medical-Surgical, INC. | $21.00 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $20.97 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $16.68 | 2019 | |
| Apyx Medical Corporation | $15.38 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $14.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.